Compared to other neuropeptides, CGRP levels were consistently elevated in external jugular vein blood samples during the pain phase of migraine [33] and 5-hydroxytryptamine (5-HT, serotonin) receptors (5-HT1B and 5-HT1D) agonists (e.g., triptans) are effective suppressors of CGRP release and significantly abort migraine attacks [34]. The gene discussed is HTR1B; the disease is migraine disorder.